Nursing and midwifery students come from all walks of life. They bring their own unique backgrounds, cultures, and beliefs to the table. But how well are these aspects considered in their education? A recent study looked into this very question. It focused on how spirituality and religion can be bet
Europe is stepping up its game in the crypto world, and Lithuania is leading the charge. Starting January 1, this small EU nation is set to enforce some of the strictest crypto rules on the continent. The central bank has made it clear that any platform operating without proper authorization will fa
Money is tight, and people are getting creative. With prices still high, Americans are rethinking what to put on their holiday wish lists. A recent study shows that many are now eyeing cryptocurrency as a gift option. Prices are still up compared to a few years ago. Housing, food, and other basics
Last week, President Donald Trump's net worth got a massive boost when shares of Trump Media & Technology Group soared after announcing a merger with TAE Technologies, a nuclear fusion company. This deal is worth $6 billion, and it's causing quite a stir. The merger is controversial because it crea
Coforge, an Indian tech company, is making a big move. They're buying Encora for $2. 35 billion. This isn't cash changing hands, though. Instead, Coforge is offering shares in exchange for Encora. Encora's owners, like Advent International and Warburg Pincus, will get about 20% of Coforge. That's a
The JonBenet Ramsey murder case, which has baffled investigators for nearly three decades, is seeing a fresh wave of optimism due to advancements in DNA technology. Boulder police, who have faced criticism for their handling of the case, recently emphasized that the investigation remains a top prior
A legal battle is unfolding in New York City between a luxury skyscraper and its historic neighbor. The dispute centers around damage caused by construction and unfulfilled promises. Gainsborough Studios, a co-op building dating back to 1908, is suing the developer of 220 Central Park South for over
The Reiner family's story is a complex mix of fame, struggles, and tragedy. Over the years, police visited their home multiple times, hinting at underlying issues. In 2013, 2014, 2017, and twice in 2019, law enforcement responded to various calls. These ranged from welfare checks to more serious inc
Pfizer's stock took a hit recently, and it's all tied to a serious issue with one of their drugs. A patient in a long-term study for Hympavzi, a treatment for hemophilia, passed away due to severe complications. This news came out in December 2025, and it's got people talking. The patient had hemop
In a surprising turn of events, the U. S. government has reached an agreement with nine major pharmaceutical companies. The most talked-about part of this deal is Bristol Myers Squibb's decision to provide its popular blood thinner, Eliquis, at no cost to Medicaid recipients starting next year. Thi
